Related references
Note: Only part of the references are listed.B cells and antibodies in the defense against Mycobacterium tuberculosis infection
Jacqueline M. Achkar et al.
IMMUNOLOGICAL REVIEWS (2015)
Evaluation of Antigen-Specific Immunoglobulin G Responses in Pulmonary Tuberculosis Patients and Contacts
Yun-Gyoung Hur et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Analysis of Th1, Th17 and regulatory T cells in tuberculosis case contacts
R. E. Garcia Jacobo et al.
CELLULAR IMMUNOLOGY (2014)
Effect of Isoniazid Therapy for Latent TB Infection on QuantiFERON-TB Gold In-Tube Responses in Adults With Positive Tuberculin Skin Test Results in a High TB Incidence Area
John L. Johnson et al.
CHEST (2014)
Isoniazid Induces Apoptosis Of Activated CD4+ T Cells IMPLICATIONS FOR POST-THERAPY TUBERCULOSIS REACTIVATION AND REINFECTION
Sultan Tousif et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
A Trial of Mass Isoniazid Preventive Therapy for Tuberculosis Control
Gavin J. Churchyard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Tuberculin Skin Test Reversion following Isoniazid Preventive Therapy Reflects Diversity of Immune Response to Primary Mycobacterium tuberculosis Infection
Denise F. Johnson et al.
PLOS ONE (2014)
Impact of Co-Infections and BCG Immunisation on Immune Responses among Household Contacts of Tuberculosis Patients in a Ugandan Cohort
Irene A. Biraro et al.
PLOS ONE (2014)
Perspectives on host adaptation in response to Mycobacterium tuberculosis: Modulation of inflammation
Anca Dorhoi et al.
SEMINARS IN IMMUNOLOGY (2014)
Circulating mycobacterial-reactive CD4+T cells with an immunosuppressive phenotype are higher in active tuberculosis than latent tuberculosis infection
K. Kim et al.
TUBERCULOSIS (2014)
Persistent BCG bacilli perpetuate CD4 T effector memory and optimal protection against tuberculosis
Daryan A. Kaveh et al.
VACCINE (2014)
Interferon-γ ELISPOT as a Biomarker of Treatment Efficacy in Latent Tuberculosis Infection A Clinical Trial
Ifedayo M. Adetifa et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Human phagosome processing of Mycobacterium tuberculosis antigens is modulated by interferon-γ and interleukin-10
Karen Bobadilla et al.
IMMUNOLOGY (2013)
IL-10 Dependent Suppression of Type 1, Type 2 and Type 17 Cytokines in Active Pulmonary Tuberculosis
Nathella Pavan Kumar et al.
PLOS ONE (2013)
Long-Lived Memory B-Cell Responses following BCG Vaccination
Ismail Sebina et al.
PLOS ONE (2012)
6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial
Taraz Samandari et al.
LANCET (2011)
New Regimens to Prevent Tuberculosis in Adults with HIV Infection
Neil A. Martinson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Immunological biomarkers of tuberculosis
Gerhard Walzl et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Increased IgG1, IFN-γ, TNF-α and IL-6 responses to Mycobacterium tuberculosis antigens in patients with Tuberculosis are lower after chemotherapy
Ana Marcia M. Mattos et al.
INTERNATIONAL IMMUNOLOGY (2010)
Understanding Latent Tuberculosis: A Moving Target
Philana Ling Lin et al.
JOURNAL OF IMMUNOLOGY (2010)
Factors that deregulate the protective immune response in tuberculosis
Rogelio Hernandez-Pando et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2009)
Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease
Jayne S. Sutherland et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement
U. Mack et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Tuberculosis Is Associated with a Down-Modulatory Lung Immune Response That Impairs Th1-Type Immunity
Alexandre S. Almeida et al.
JOURNAL OF IMMUNOLOGY (2009)
Biomarker Changes Associated with Tuberculin Skin Test (TST) Conversion: A Two-Year Longitudinal Follow-Up Study in Exposed Household Contacts
Rabia Hussain et al.
PLOS ONE (2009)
Mannose-capped lipoarabinomannan- and prostaglandin E2-dependent expansion of regulatory T cells in human Mycobacterium tuberculosis infection
Ankita Garg et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Latent tuberculosis infection treatment and T-Cell responses to Mycobacterium tuberculosis-specific antigens
Cynthia B. E. Chee et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis:: a pilot study
Delia Goletti et al.
RESPIRATORY RESEARCH (2007)
Dynamic antigen-specific point-source exposure to T-cell responses after Mycobacterium tuberculosis
Katie Ewer et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
The ESAT-6/CFP-10 secretion system of Mycobacterium marinum modulates phagosome maturation
Tracy Tan et al.
CELLULAR MICROBIOLOGY (2006)
Effect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens
KA Wilkinson et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Long-term control of Mycobacterium tuberculosis infection is mediated by dynamic immune responses
V Lazarevic et al.
JOURNAL OF IMMUNOLOGY (2005)
Counting antigen-specific T cells: A new approach for monitoring response to tuberculosis treatment?
A Lalvani
CLINICAL INFECTIOUS DISEASES (2004)
Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders
GAW Rook et al.
SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2004)
A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response
MB Reed et al.
NATURE (2004)
IL-4 in tuberculosis: implications for vaccine design
GAW Rook et al.
TRENDS IN IMMUNOLOGY (2004)
Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis
C Manca et al.
INFECTION AND IMMUNITY (2004)
Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-4δ2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation
HA Fletcher et al.
IMMUNOLOGY (2004)
Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high evels of Th1 cytokines and the IL-4 antagonist IL-4δ2
A Demissie et al.
JOURNAL OF IMMUNOLOGY (2004)
Cross-linking of the mannose receptor on monocyte-derived dendritic cells activates an anti-inflammatory immunosuppressive program
M Chieppa et al.
JOURNAL OF IMMUNOLOGY (2003)
Duration of efficacy of treatment of latent tuberculosis infection in HIV infected adults
JL Johnson et al.
AIDS (2001)
Tuberculosis: Latency and reactivation
JL Flynn et al.
INFECTION AND IMMUNITY (2001)
Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis
GT Seah et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Clearance and organ distribution of Mycobacterium tuberculosis lipoarabinomannan (LAM) in the presence and absence of LAM-binding immunoglobulin M
A Glatman-Freedman et al.
INFECTION AND IMMUNITY (2000)
Share Paper
